Aclaris Therapeutics, Inc., announced the FDA approved ESKATA™ (hydrogen peroxide) topical solution, 40% (w/w) for the treatment of seborrheic keratoses (SKs). SKs are non-cancerous skin growths that affect more than

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In